137 related articles for article (PubMed ID: 22915826)
1. Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research.
Dainesi SM; Goldbaum M
J Med Ethics; 2012 Dec; 38(12):757-62. PubMed ID: 22915826
[TBL] [Abstract][Full Text] [Related]
2. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
[TBL] [Abstract][Full Text] [Related]
3. For-profit clinical trials in developing countries--those troublesome patient benefits.
Schuklenk U
Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
[No Abstract] [Full Text] [Related]
4. Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors.
Mello MM; Clarridge BR; Studdert DM
Account Res; 2005; 12(3):163-91. PubMed ID: 16634168
[TBL] [Abstract][Full Text] [Related]
5. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
Klitzman R
Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
[TBL] [Abstract][Full Text] [Related]
6. Freebies for subject 641: a discussion of the ethical prospect of providing drug trial subjects with post-trial access to the drug tested--a Canadian perspective.
Hutt LE
Health Law J; 1998; 6 Spec No():169-87. PubMed ID: 14746066
[TBL] [Abstract][Full Text] [Related]
7. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
Caulfield T
Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
[No Abstract] [Full Text] [Related]
8. Mind the gap: An empirical study of post-trial access in HIV biomedical prevention trials.
Haire B; Jordens C
Dev World Bioeth; 2015 Aug; 15(2):85-97. PubMed ID: 26193849
[TBL] [Abstract][Full Text] [Related]
9. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
Newcombe JP; Kerridge IH
Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
[TBL] [Abstract][Full Text] [Related]
10. Expanding disclosure of conflicts of interest: the views of stakeholders.
Brody BA; Anderson C; McCrary SV; McCullough L; Morgan R; Wray N
IRB; 2003; 25(1):1-8. PubMed ID: 12833897
[No Abstract] [Full Text] [Related]
11. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
Puttagunta PS; Caulfield TA; Griener G
Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
[TBL] [Abstract][Full Text] [Related]
12. Review of policies for injuries to research participants in India.
Thatte UM; Kulkarni-Munshi R; Kalekar SA
J Med Ethics; 2009 Feb; 35(2):133-9. PubMed ID: 19181889
[TBL] [Abstract][Full Text] [Related]
13. Forthcoming practical framework for ethics committees and researchers on post-trial access to the trial intervention and healthcare.
Sofaer N; Lewis P; Davies H
J Med Ethics; 2014 Apr; 40(4):217-8. PubMed ID: 23645524
[No Abstract] [Full Text] [Related]
14. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.
Schulman KA; Seils DM; Timbie JW; Sugarman J; Dame LA; Weinfurt KP; Mark DB; Califf RM
N Engl J Med; 2002 Oct; 347(17):1335-41. PubMed ID: 12397192
[TBL] [Abstract][Full Text] [Related]
15. Committees for Ethics in Research involving human subjects.
Hossne WS; Vieira S; De Freitas CB
J Int Bioethique; 2008; 19(1-2):131-41, 200. PubMed ID: 18664006
[TBL] [Abstract][Full Text] [Related]
16. Difficulties in negotiating research access.
Ames JC; Thompson S; Thurston MN
Bull Med Ethics; 2001 Mar; (166):15-7. PubMed ID: 11878334
[No Abstract] [Full Text] [Related]
17. The perverse consequences of a proposed global tax on research.
MacDonald C; Walton N
Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
[No Abstract] [Full Text] [Related]
18. E-survey with researchers, members of ethics committees and sponsors of clinical research in Brazil: an emerging methodology for scientific research.
Dainesi SM; Goldbaum M
Rev Bras Epidemiol; 2012 Dec; 15(4):705-13. PubMed ID: 23515767
[TBL] [Abstract][Full Text] [Related]
19. Social contexts influence ethical considerations of research.
Gordon JB; Levine RJ; Mazure CM; Rubin PE; Schaller BR; Young JL
Am J Bioeth; 2011 May; 11(5):24-30. PubMed ID: 21534146
[TBL] [Abstract][Full Text] [Related]
20. Blood, sweat and tears.
Magnus D
Am J Bioeth; 2006; 6(3):1-2. PubMed ID: 16754438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
